v3.26.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows provided by (used in) operating activities    
Net income (loss) $ 1,492,327 $ 2,470,139
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities    
Amortization, accretion and depreciation (72,991) 2,437
Equity in undistributed (earnings) losses of other ventures (18,316) (11,210)
Net realized and unrealized (gains) losses on investments 1,180,128 (496,597)
Change in:    
Premiums receivable (281,770) (840,280)
Prepaid reinsurance premiums (452,826) (328,425)
Reinsurance recoverable 71,651 396,297
Deferred acquisition costs and value of business acquired (149,217) (103,683)
Reserve for claims and claim expenses (8,150) 1,409,369
Unearned premiums 591,278 1,036,203
Reinsurance balances payable 189,546 (101,254)
Other (207,235) (222,864)
Net cash provided by (used in) operating activities 2,334,425 3,210,132
Cash flows provided by (used in) investing activities    
Proceeds from sales and maturities of fixed maturity investments trading 19,285,170 10,834,466
Purchases of fixed maturity investments trading (20,448,405) (10,265,197)
Proceeds from sales of short term investments 33,716,283 30,291,467
Purchases of short term investments (32,904,204) (32,139,997)
Proceeds from sales of equity investments 472,479 1,193
Purchases of equity investments (647,378) (1,313,401)
Proceeds from sales of other investments 950,782 803,391
Purchases of other investments (1,233,775) (942,036)
Purchases of investments in other ventures (25,810) (1,037)
Return of investments in other ventures 2,624 248
Net settlements of derivatives 3,910 430,509
Net cash provided by (used in) investing activities (828,324) (2,300,394)
Cash flows provided by (used in) financing activities    
Dividends paid – common shares (51,531) (57,266)
Dividends paid – preference shares (26,531) (26,531)
RenaissanceRe common share repurchases (1,012,608) (939,637)
Repayment of debt 0 (450,000)
Issuance of debt, net of expenses 0 789,903
Repayment of Medici Revolving Credit Facility 0 (75,000)
Drawdown of Medici Revolving Credit Facility 0 75,000
Subscriptions of third-party redeemable noncontrolling interest shares 10,600 121,616
Redemptions of third-party redeemable noncontrolling interest shares (1,016,741) (304,655)
Taxes paid on withholding shares (27,376) (21,596)
Net cash provided by (used in) financing activities (2,124,187) (888,166)
Effect of exchange rate changes on foreign currency cash (14,813) 3,392
Net increase (decrease) in cash and cash equivalents (632,899) 24,964
Cash and cash equivalents, beginning of period 1,731,181 1,676,604
Cash and cash equivalents, end of period $ 1,098,282 $ 1,701,568